POTENT ANTIBODIES: China’s state-owned medical products maker is collecting plasma from the blood of people who have recovered from the novel coronavirus after discovering it helped critically ill patients, according to a Bloomberg report on Friday (February 14, 2020). Photo shows two medical personnel work in the patients' ward in Jinyintan Hospital, designated for critical COVID-19 patients, in Wuhan in central China's Hubei province on Feb. 13, 2020.